Program

 
2018.09.24 
5.00 pm Registration
6.00 pm Remarks
Enzo Tramontano  Organizing commitee coordinator
Giorgio Palù President  of the European Society for Virology and of the Società Italiana di Virologia Italian Society for Virology – SIV-ISV
José Esté President of the International Society for Antiviral Research
Inaugural Lecture  
José Esté Host-pathogen interactions and antiviral drug potency
Fundaciò Irsicaixa (Spain)
2018.09.25
9.00 am Plenary lectures 
Stephan Ludwig Structural Targeting signal transduction pathways to fight the flu
University of Münster, Germany
Stuart Le Grice Small molecule targeting of viral RNA regulatory elements
National Cancer Institute (USA)
11.00-11.15 am Coffee Break
11.15 am Plenary lectures 
Andrea Brancale Computer-aided design of novel antivirals
Cardiff University (UK)
Daniel Appella Disrupting HIV Nucleocapsid Protein with Mercaptobenzamides
NIH (USA)
1.00-2.00 pm Lunch  
2.00-3.30 pm Poster session 1
3.30-5.00 pm Selected oral communications 
6.00 pm Coffee break
6.30-7.30 pm  Discussion groups 
2018.09.26 
9.00 am Plenary lectures 
Raffaele De Francesco From the elucidation of HCV life-cycle to the development of highly effective antivirals
NIMG, Italy
Michelle Hastings Therapeutic Targeting of Gene Expression with Antisense 
Rosalind Franklin University, USA
11.00-11.15 am Coffee Break
11.15 am Round table: Working in a company after the PhD 
1.00-2.00 pm Lunch
2.00-3.30 pm Poster session and Bio-tech companies presentation desk  
3.30-5.00 pm Selected oral communications 
6.00 pm Coffee break
6.30-7.30 pm  Discussion groups 
2018.09.27
9.00 am Plenary lectures 
Zlatko Janeba The progress in development of inhibitors of viral reverse transcriptase
Institute of Organic Chemistry and Biochemistry CAS, Prague
Vincenzo Summa Discovery of Grazoprevir an HCV pangenotype protease inhibitor approved for interferon free therapy to cure  the HCV infected patients
IRBM (Italy)
11.00-11.15 am Coffee Break
11.15 am Plenary lectures 
Reuben Harris Targeting Evolvability
University of Minnesota (USA)
Maurizio Botta Antiviral compounds with broad spectrum activity on enveloped viruses
University of Siena (Italy)
1.00 pm Lunch
Free afternoon
2018.09.28
9.00 am Plenary lectures 
Thomas Mertens Re-emergence of antibodies in antiviral therapy
University of Ulm (Germany)
Cristina Parolin Gene therapy approaches for the treatment of HIV-1 infection
Padova University (Italy)
11.00-11.15 am Coffee Break
11.15 am Plenary lectures 
Graciela Andrei Viral DNA polymerases: effects of amino acid substitutions on viral adaptation and evolution
KU Leuven (Belgium)
Simona Distinto In silico virtual screening approaches for antiviral drug discovery
University of Cagliari (Italy)
1.00-2.00 pm Lunch
2.00-3.30 pm Poster session 
3.30-5.00 pm Selected oral communications 
6.00 pm Coffee break
6.30-7.30 pm  Discussion groups 
2018.09.29
                                            Breakfast and leaving
credits unica.it Università degli Studi di Cagliari
C.F.: 80019600925 - P.I.: 00443370929
note legali | privacy